You searched for "field"

1272 results found

Presenting the new Surgitrac website!

We are thrilled to announce the launch of our brand-new website—crafted with our audience in mind.

Oertli Instrumente AG achieves milestone with FDA 510(k) clearance for Faros surgical system

Oertli Instrumente AG, a leader in innovative surgical solutions for ophthalmology, is proud to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance for the worldwide established Faros anterior cataract surgery system. This milestone underscores Oertli's global reach and...

Haag-Streit UK to offer iTrack Advance ‘Meet the experts’ sessions at UKEGS 2024

Haag-Streit UK will be exhibiting as a gold sponsor at the United Kingdom & Eire Glaucoma Society (UKEGS) event in Southampton on the 9th and 10th October 2024, where they will be showcasing the iTrack Advance microcatheter. Delegates will have...

New Clinical Specialist for the North and National Refractive Specialist

Surgitrac is pleased to announce the appointment of Jessica Seers as Clinical Specialist for the North and National Refractive Specialist for lenses. With a strong clinical background and a passion for ophthalmology, Jessica steps into a dual role that supports...

RANZCO Congress 2025

The Royal Australian and New Zealand College of Ophthalmologists Annual Congress 2025

Sheraz Daya awarded prestigious IIRSI gold medal for contribution to ophthalmology

Centre for Sight, the UK’s leading and most trusted centre of excellence for advanced eye care, innovation and life-changing results, is proud to announce that its Founder and Medical Director, Sheraz Daya, has been awarded the prestigious IIRSI Gold Medal...

Newmedica welcomes GIRFT glaucoma guidance but calls for equitable commissioning to protect patient access

Newmedica has welcomed the publication of NHS England’s Getting It Right First Time (GIRFT) Best Practice Guidance for Glaucoma Services, recognising it as an important step toward improving consistency and outcomes for patients across England. The guidance’s emphasis on patient...

What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace

Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...

Unconscious bias

Swansea University invited me to an Away Day. There was a whole day of lectures planned at a hotel conference suite just outside Swansea but due to clinic commitments I only caught the afternoon session; a ‘workshop’, on how to...

Quiz Dec/Jan 2020

History A 69-year-old female patient was referred to the uveitis clinic from her local district general hospital with a left posterior uveitis which had been unresponsive to high dose steroids. She had no other previous ophthalmic history nor significant systems...

Syringocystadenoma papilliferum in the right lateral canthus

Syringocystadenoma papilliferum (SP) is an exceedingly rare, benign adnexal tumour primarily affecting the skin. It is characterised by the presence of cystic structures and papillary projections. This uncommon dermatological condition is typically found in areas rich in apocrine glands, such...

Could the sclera be key to glaucoma?

The glaucomas are a group of conditions characterised by optic neuropathy and associated visual field defects. Of these, chronic open-angle glaucoma (COAG) – diagnosed on the basis of progressive structural changes to the optic nerve head (ONH) and nerve fibre...